Lymphoedema is a chronic, often life-changing condition that affects thousands of Australians, yet it remains under-recognised and misunderstood. As part of Lymphoedema Awareness Month this March, Cancer Rehabilitation & Lymphatic Solutions (CRLS) is advocating for greater awareness, earlier detection, and access to innovative treatments to help those at risk – because catching it early can make all the difference.
Lymphoedema occurs when the lymphatic system is compromised, leading to fluid buildup, swelling, discomfort, and reduced mobility. It frequently develops following cancer treatments such as surgery, chemotherapy, and radiation therapy, and without proper monitoring, it can become a lifelong condition.
“Too many patients don’t realise they’re at risk until the swelling starts, and by then, it’s much harder to manage,” says Kate Perkins, Cancer Rehabilitation OT and Lymphoedema Therapist at CRLS. “By integrating early intervention strategies and targeted therapies, we can significantly reduce the impact of lymphoedema on a person’s quality of life.”
Who’s at Risk?
Lymphoedema affects patients recovering from a range of cancers, including breast cancer, gynaecological cancers, melanoma, and head and neck cancer (HNC). Studies show that:
🔹 Over 50% of head and neck cancer patients will develop lymphoedema after treatment, affecting their ability to swallow, speak, and breathe. Some research suggests this could be as high as 75%.
🔹 Approximately 1 in 5 breast cancer survivors will experience Breast Cancer-Related Lymphoedema, which causes arm, chest, and trunk swelling, discomfort, and long-term functional limitations.
If left untreated, lymphoedema can progress to a chronic stage, significantly impacting a person’s independence and well-being.
Advancing Lymphoedema Treatment at CRLS
CRLS combines hands-on therapy with cutting-edge medical technology to improve outcomes for those at risk of developing lymphoedema.
One of the most promising advancements is OncoLaser™, an innovative system co-founded by Kate Perkins and Dr. Catherine Norton. This protocol incorporates MLS® Laser Therapy, a non-invasive treatment that helps:
- Reduce swelling and improve circulation
- Minimise the onset of lymphoedema in at-risk patients
- Support lymphatic health and post-treatment recovery
Another breakthrough is SOZO bioimpedance spectroscopy, an advanced diagnostic tool that detects fluid buildup before symptoms appear, allowing for early intervention before lymphoedema progresses.
“OncoLaser™ is changing the way we approach lymphoedema care,” says Perkins. “It’s not just about managing symptoms – it’s about actively improving outcomes, reducing discomfort, and getting people back to living their lives.”
Get Involved
This Lymphoedema Awareness Month, CRLS encourages patients, healthcare professionals, and the wider community to advocate for better awareness, education, and early intervention.
World Lymphoedema Day on March 6 is a reminder that this condition deserves greater attention and support. If you or a loved one has undergone cancer treatment, early screening and intervention can help prevent long-term complications.
To learn more about lymphoedema risk, early detection, and treatment options, visit www.crls.au or contact Kate Perkins and the team at (02) 4312 7033.